Cargando…

Antioxidant Regulation of Cell Reprogramming

Discovery of induced pluripotent stem cells (iPSCs) has revolutionized regeneration biology, providing further mechanistic insights and possible therapeutic applications. The original discovery by Yamanaka and co-workers showed that the expression of four transcription factors in fibroblasts resulte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Yuichiro J., Shults, Nataliia V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721077/ https://www.ncbi.nlm.nih.gov/pubmed/31434270 http://dx.doi.org/10.3390/antiox8080323

Ejemplares similares

Redox Biology of Right-Sided Heart Failure
por: Shults, Nataliia V., et al.
Publicado: (2018)

Effects of Bcl-2/Bcl-x(L) Inhibitors on Pulmonary Artery Smooth Muscle Cells
por: Rybka, Vladyslava, et al.
Publicado: (2018)

Oxidative profiling of the failing right heart in rats with pulmonary hypertension
por: Wang, Xinhong, et al.
Publicado: (2017)

Major vault protein in cardiac and smooth muscle
por: Shults, Nataliia V., et al.
Publicado: (2016)

Apoptosis-based therapy to treat pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2016)

Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination
por: Sullivan, Robert D., et al.
Publicado: (2023)

Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer’s disease brain
por: Ding, Qiyue, et al.
Publicado: (2020)

Natural reversal of pulmonary vascular remodeling and right ventricular remodeling in SU5416/hypoxia-treated Sprague-Dawley rats
por: Zungu-Edmondson, Makhosazane, et al.
Publicado: (2017)

COVID-19 patients may become predisposed to pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2021)

Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer’s Disease
por: Ding, Qiyue, et al.
Publicado: (2021)

Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension
por: Shults, Nataliia V., et al.
Publicado: (2019)

Transmission Electron Microscopy Study of Mitochondria in Aging Brain Synapses
por: Rybka, Vladyslava, et al.
Publicado: (2019)

SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells
por: Suzuki, Yuichiro J., et al.
Publicado: (2021)

Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
por: Chitimus, Diana Maria, et al.
Publicado: (2020)

Regulation of Immune Cell Functions by Metabolic Reprogramming
por: Kim, Jaehong
Publicado: (2018)

Oncogenic regulation of tumor metabolic reprogramming
por: Tarrado-Castellarnau, Míriam, et al.
Publicado: (2016)

Genetic and epigenetic regulators of retinal Müller glial cell reprogramming
por: Xiao, Xueqi, et al.
Publicado: (2023)

Metabolism Is a Key Regulator of Induced Pluripotent Stem Cell Reprogramming
por: Spyrou, James, et al.
Publicado: (2019)

Vasa Vasorum Lumen Narrowing in Brain Vascular Hyalinosis in Systemic Hypertension Patients Who Died of Ischemic Stroke
por: Gychka, Sergiy G., et al.
Publicado: (2020)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Reprogramming Cells for Brain Repair
por: Guarino, Alyx T., et al.
Publicado: (2013)

Hypoxia in Cell Reprogramming and the Epigenetic Regulations
por: Nakamura, Nariaki, et al.
Publicado: (2021)

The ERK and JNK pathways in the regulation of metabolic reprogramming
por: Papa, Salvatore, et al.
Publicado: (2018)

The biological role of metabolic reprogramming in pancreatic cancer
por: Suzuki, Tatsunori, et al.
Publicado: (2020)

The role of pioneer transcription factors in the induction of direct cellular reprogramming()
por: Horisawa, Kenichi, et al.
Publicado: (2023)

Metabolic Reprogramming in Modulating T Cell Reactive Oxygen Species Generation and Antioxidant Capacity
por: Rashida Gnanaprakasam, Josephin N., et al.
Publicado: (2018)

Dissecting microRNA-mediated regulation of stemness, reprogramming, and pluripotency
por: Lee, Young Jin, et al.
Publicado: (2016)

Regulation of Metabolic Reprogramming by Long Non-Coding RNAs in Cancer
por: Sellitto, Assunta, et al.
Publicado: (2021)

Metabolic Reprogramming in Mitochondria of Myeloid Cells
por: Zuo, Hao, et al.
Publicado: (2019)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

Pioneer transcription factors in cell reprogramming
por: Iwafuchi-Doi, Makiko, et al.
Publicado: (2014)

Reprogramming cell fates by small molecules
por: Ma, Xiaojie, et al.
Publicado: (2017)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Metabolic Reprogramming in Tumor Endothelial Cells
por: García-Caballero, Melissa, et al.
Publicado: (2022)

Reprogramming Cells to Make Insulin
por: McKimpson, Wendy M, et al.
Publicado: (2019)

Reprogramming cells with synthetic proteins
por: Yang, Xiaoxiao, et al.
Publicado: (2015)

Epigenetic Regulation of B Lymphocyte Differentiation, Transdifferentiation, and Reprogramming
por: Barneda-Zahonero, Bruna, et al.
Publicado: (2012)

Antioxidant-Conjugated Peptide Attenuated Metabolic Reprogramming in Pulmonary Hypertension
por: Valuparampil Varghese, Mathews, et al.
Publicado: (2020)

Macrophage reprogramming for therapy
por: Bart, Valentina M. T., et al.
Publicado: (2021)

Transcriptional regulation and nuclear reprogramming: roles of nuclear actin and actin-binding proteins
por: Miyamoto, Kei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bj5l5ut3bikgjlmeopeusodkv1